Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Public ClinicalTrials.gov record NCT00219284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-center, Randomized, Open-label Study With Blinded Raters to Evaluate the Effects of Immediate Versus Delayed Switch to Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease With End-of-dose Wearing Off
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess motor function and quality of life (QoL) in Parkinson's disease (PD) subjects with end-of-dose wearing off, comparing immediate and delayed switch to carbidopa/levodopa and entacapone.
Study identification
- NCT ID
- NCT00219284
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 359 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Mar 30, 2017
2005 – 2008
United States locations
- U.S. sites
- 41
- U.S. states
- 20
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85006 | — |
| Not listed | Fullerton | California | 92835 | — |
| Not listed | Irvine | California | 92618 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | Reseda | California | 91355 | — |
| Not listed | Stanford | California | 94305 | — |
| Not listed | Fort Collins | Colorado | 80524 | — |
| Not listed | Washington D.C. | District of Columbia | 20007 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Bradenton | Florida | 34205 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Naples | Florida | 34102 | — |
| Not listed | Palm Beach | Florida | 33418 | — |
| Not listed | Plantation | Florida | 33324 | — |
| Not listed | Pompano Beach | Florida | 33060 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Flossmoor | Illinois | 60402 | — |
| Not listed | Lenexa | Kansas | 66214 | — |
| Not listed | Topeka | Kansas | 66606 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Bingham Farms | Michigan | 48025 | — |
| Not listed | Southfield | Michigan | 48034 | — |
| Not listed | Hattiesburg | Mississippi | 39401 | — |
| Not listed | Columbia | Missouri | 65201 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | Ridgewood | New Jersey | 07450 | — |
| Not listed | Commack | New York | 11725 | — |
| Not listed | Durham | North Carolina | 27705 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Bellevue | Ohio | 44811 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Tualatin | Oregon | 97602 | — |
| Not listed | East Stroudsburg | Pennsylvania | 18301 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Spokane | Washington | 99204 | — |
| Not listed | Tacoma | Washington | 98405 | — |
| Not listed | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00219284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00219284 live on ClinicalTrials.gov.